Cipla, Kemwell Biopharma, Manipal forge cell therapy alliance in US Ruchika Sharma9 Jan 2024 11:32 AM ISTMumbai: Cipla (EU) Limited, UK a wholly owned subsidiary of Cipla Limited, hereinafter referred to as Cipla has announced a strategic...
NPPA fixes Retail Prices of 19 Formulations, Details Susmita Roy6 Jan 2024 6:00 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers, Government...
Conduct BE study and clinical trial: CDSCO Panel tells Cipla on Formoterol Fumarate Dihydrate, glycopyrronium inhaler Dr. Divya Colin19 Dec 2023 6:58 PM ISTNew Delhi: Rejecting the proposal for clinical trial and bioequivalence (BE) study waiver presented by drug major Cipla, the Subject Expert Committee...
Cipla expands patient reach to remotest towns by furthering investment in GoApptiv Roshni Dhar16 Dec 2023 5:12 PM ISTCipla Limited has announced that it has agreed to further invest Rs 42 crore (approx.) in digital tech company GoApptiv Private Limited. This...
Health Bulletin 16/December/2023 Roshni Dhar16 Dec 2023 4:42 PM ISTHere are the top health stories for the day:Woman's eyes go missing after post-mortem: Two doctors arrestedPolice on Wednesday arrested two doctors...
Cipla to further invest Rs 42 crore in GoApptiv Ruchika Sharma15 Dec 2023 1:30 PM ISTMumbai: Cipla Limited has announced that it has agreed to further invest Rs 42 crore (approx.) in digital tech company GoApptiv Private Limited.This...
Cipla US arm recalls Vigabatrin for Oral Solution, USP 500mg over pouch leakage issues Ruchika Sharma11 Dec 2023 3:00 PM ISTCipla has not received any reports of adverse events related to this recall.
Submit Justification to study Tocilizumab in patients with giant cell arteritis: CDSCO Panel Tells Cipla Dr. Divya Colin30 Nov 2023 6:00 PM ISTNew Delhi: Reviewing the protocol presented by the drug major Cipla for the approval post-marketing active surveillance of Tocilizumab in patients of...
USFDA issues warning letter to Cipla Pithampur facility Ruchika Sharma20 Nov 2023 4:30 PM ISTMumbai: Cipla has announced that the Company has received a warning letter from the United States Food and Drug Administration (USFDA) for the...
Indian pharmaceutical market registers 9 percent growth in September: IQVIA Report Susmita Roy3 Nov 2023 5:43 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has witnessed a spike of nine percent in September 2023, according to International Quality and...
NPPA fixes retail price of 29 formulations, details Dr. Divya Colin30 Oct 2023 4:30 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Cipla reports bigger-than-expected rise in Q2 profit Ruchika Sharma28 Oct 2023 6:15 AM ISTHigher market share in cancer drugs Revlimid and Lanreotide and lower price erosion have helped Cipla's sales in the North American market, analysts...
